Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Vaxcyte, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 75 | 78 | +3 |
| Shares | 43.2M | 43.2M | −24.3K (−0.1%) |
| Value | $972.7M | $1.10B | +$123.2M (+12.7%) |
New holders (8)
Institutions that held Vaxcyte, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Great Point Partners LLC | 98,061 | $2.49M | 0.59% |
| Temasek Holdings (Private) Ltd | 27,272 | $692.0K | 0.00% |
| SG Americas Securities, LLC | 25,670 | $651.0K | 0.00% |
| ExodusPoint Capital Management, LP | 14,300 | $363.0K | 0.01% |
| Algert Global LLC | 11,286 | $286.0K | 0.04% |
| Manchester Capital Management LLC | 1,500 | $38.0K | 0.01% |
| TCI Wealth Advisors, Inc. | 132 | $3.00K | 0.00% |
| Parallel Advisors, LLC | 28 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Vaxcyte, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Voloridge Investment Management, LLC | 70,341 | $1.58M |
| Employees Retirement System of Texas | 58,441 | $1.32M |
| Squarepoint Ops LLC | 16,504 | $372.0K |
| O'Shaughnessy Asset Management, LLC | 426 | $10.0K |
| Lindbrook Capital, LLC | 17 | $0 |